Picture of Infant Bacterial Therapeutics AB logo

IBT B — Infant Bacterial Therapeutics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Infant Bacterial Therapeutics Q3 Operating Loss SEK 48.5 Mln

Nov 13 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST:

Q3 NET SALES SEK 0 THOUSAND

Q3 OPERATING PROFIT SEK -48,457 THOUSAND

Source text: ID:nMFNHkk7b

Further company coverage: [IBTb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Infant Bacterial Therapeutics AB

See all news